In April 2015, U.S. FDA approved the deoxycholate acid injection Kybella of Kythera Biopharmaceuticals, Inc. which made the injection lipolysis procedure one of the mainstream minimally invasive technique for body fat loss.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32473
The injection lipolysis technique for fat loss is well adopted in European and American countries from the last couple of years while the adoption is a little low in Asia pacific regions. Growing prevalence of diabetes, obesity and demand for cosmetic surgeries for fat reduction is expected to accelerate the injection lipolysis market growth over forecast years.
Injection Lipolysis Market: Segmentation
Based on drug type, Injection lipolysis market can be segmented as:
- Deoxycholic Acid
Based on the treatment site, Injection lipolysis market can be segmented as:
- Facial Fat Deposits
- Submental Fat
- Upper Arm Fat
- Abdominal Fat
- Thighs Fat
- Knee Fat
- Buttock Fat
Based on end-user, Injection lipolysis market can be segmented as:
- Dermatology and Cosmetic Clinics
- Ambulatory Surgical Centers
- AbbVie Inc.
- Shandong Chenguang Biotechnology Co. Ltd.
- Shijiazhuang Tiantian Technology Co. Ltd.
- NEXUS PHARMA CO. LTD.
- Hebei Chefhi International Trade Co. Ltd.
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – firstname.lastname@example.org
Website – https://www.persistencemarketresearch.com